Like other GLP-1 drugs, Foundayo can cause side effects such as nausea, constipation, diarrhea, vomiting, abdominal pain, and headache, according to the FDA
Growth is further accelerated by rapid expansion within the pharmaceutical, food additive, and cosmetics industries, alongside increasing prevalence of lifestyle-induced diseases and urban air quality concerns that heighten consumer interest in antioxidant protection and cellular health support
Genetic factors are also at play, and scientists are trying to understand more about this
The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial
Researchers must handle this compound in accordance with their institutional biosafety guidelines